Glucocorticoid in Treatment of Adult Idiopathic Nephrotic Syndrome：a Prospective Observational Study
Status:
Completed
Trial end date:
2020-10-22
Target enrollment:
Participant gender:
Summary
This study is to assess the efficacy and safety of 8-weeks full-dose induction protocol
(prednisone 1mg/kg, maximum 60mg/day) and protracted tapering protocol in the treatment of
adult idiopathic nephrotic syndrome.